These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26475492)

  • 1. FcγRIIB mediates antigen-independent inhibition on human B lymphocytes through Btk and p38 MAPK.
    Tzeng SJ; Li WY; Wang HY
    J Biomed Sci; 2015 Oct; 22():87. PubMed ID: 26475492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
    Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
    Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
    Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
    Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
    Preissler MT; Kaiser L; Drake JR; Gosselin EJ
    Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.
    Comabella M; Montalban X; Kakalacheva K; Osman D; Nimmerjahn F; Tintoré M; Lünemann JD
    J Neuroimmunol; 2010 Jun; 223(1-2):135-7. PubMed ID: 20399509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of SM201, an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells.
    Rieth N; Carle A; Müller MA; ter Meer D; Direnberger C; Pohl T; Sondermann P
    Immunol Lett; 2014 Aug; 160(2):145-50. PubMed ID: 24472604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.
    Xiang Z; Cutler AJ; Brownlie RJ; Fairfax K; Lawlor KE; Severinson E; Walker EU; Manz RA; Tarlinton DM; Smith KG
    Nat Immunol; 2007 Apr; 8(4):419-29. PubMed ID: 17322888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
    Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
    J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.
    Kersseboom R; Kil L; Flierman R; van der Zee M; Dingjan GM; Middendorp S; Maas A; Hendriks RW
    Eur J Immunol; 2010 Sep; 40(9):2643-54. PubMed ID: 20623551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
    Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
    J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
    Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
    Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proliferation-inducing ligand sustains the proliferation of human naïve (CD27⁻) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen.
    Matsuda Y; Haneda M; Kadomatsu K; Kobayashi T
    Cell Immunol; 2015 Jun; 295(2):127-36. PubMed ID: 25880104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity.
    Rahman ZS; Alabyev B; Manser T
    J Immunol; 2007 Jan; 178(2):897-907. PubMed ID: 17202351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas.
    Graves JD; Draves KE; Craxton A; Krebs EG; Clark EA
    J Immunol; 1998 Jul; 161(1):168-74. PubMed ID: 9647221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of a MAPK docking site on human FcgammaRIIb.
    Medgyesi D; Sárközi R; Koncz G; Arató K; Váradi G; Tóth GK; Sármay G
    Immunol Lett; 2004 Mar; 92(1-2):83-90. PubMed ID: 15081531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcgammaRIIb expression on human germinal center B lymphocytes.
    Macardle PJ; Mardell C; Bailey S; Wheatland L; Ho A; Jessup C; Roberton DM; Zola H
    Eur J Immunol; 2002 Dec; 32(12):3736-44. PubMed ID: 12516568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcγRIIB and autoimmunity.
    Espéli M; Smith KG; Clatworthy MR
    Immunol Rev; 2016 Jan; 269(1):194-211. PubMed ID: 26683154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.